A blood pressure medication is voluntarily being pulled from the shelves due to impurity concerns which may lead to a cancer risk.
The Food and Drug Administration said Losartan Potassium Hydrochlorothiazide could contain an impurity that has been classified as a probable human carcinogen, known to cause cancer.
The batch affected by the recall are the 100 milligram and 25 milligram tablet with the Lot Number JB8-912.
Patients who are currently on the medication are advised to talk to their doctor before stopping use.
Losartan Potassium Hydrochlorothiazide is used to treat high blood pressure, reducing the risk of stroke, and can also be prescribed to treat kidney disease in patients with diabetes.
For more information, visit the FDA’s recall notice on their website by following this link: fda.gov/Safety/Recalls/ucm625492.htm.